Abstract
We appreciate the comments by Dr. Yuan and colleagues, who propose that fostering the activity of regulatory T cells may be an attractive strategy to treat autoimmune diseases such as inflammatory arthritis, multiple sclerosis, and systemic lupus erythematosus. Such strategies could indeed be based
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have